Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
SLS
SLS
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
SLS News
SELLAS Life Sciences Expands SLS009 Clinical Study with IMPACT-AML in Europe
Jan 14 2026
stocktwits
SELLAS Life Sciences Partners with IMPACT-AML to Advance SLS009 Clinical Trials
Jan 14 2026
Newsfilter
Oncolytics Biotech Fortifies IP Protection, Extends Pelareorep Commercial Runway to 2044
Jan 08 2026
Globenewswire
Intelligent Bio Solutions Plans $10 Million Private Placement, Shares Plunge 19.7%
Jan 02 2026
Benzinga
Ironwood Pharmaceuticals Issues FY26 Guidance, Shares Surge 57.7%
Jan 02 2026
Benzinga
ARS Pharma's Neffy Approved in China for Allergy Treatment
Jan 02 2026
NASDAQ.COM
Baidu Inc Proposes Spinoff of Kunlunxin H Shares, Stock Rises 12.3%
Jan 02 2026
Benzinga
FuelCell Energy Files for $200 Million Stock Offering, Shares Drop 8.9%
Dec 31 2025
Benzinga
Axsome Therapeutics Plans New Drug Application for AXS-12 in January, Shares Surge 16.1%
Dec 31 2025
Benzinga
OceanFirst Financial Corp. Announces $579 Million All-Stock Acquisition of Flushing, Shares Drop 7.4%
Dec 30 2025
Benzinga
CapsoVision Inc. Submits FDA 510(k) Application, Shares Surge 8.4%
Dec 30 2025
Benzinga
SELLAS Life Sciences Extends Survival in AML Patients in REGAL Trial
Dec 30 2025
NASDAQ.COM
SELLAS Life Sciences Shares Surge 16.72% on New Trial Updates
Dec 29 2025
Benzinga
Mereo BioPharma Shares Plunge 87.5% After Phase 3 Study Fails to Meet Primary Endpoints
Dec 29 2025
Benzinga
SELLAS Updates on REGAL Trial Progress with 72 Events Recorded
Dec 29 2025
Newsfilter
GT Biopharma Advances GTB-3650 Clinical Trial to Cohort 4 with 10μg/kg/day Dosing
Dec 24 2025
Globenewswire
Show More News
